Accessibility Menu
 
Australis Capital logo

Australis Capital

(OTC) AUSAF

Current Price$0.00
Market CapN/A
Since IPO (2018)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Australis Capital Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$6.37M

Net Income (TTM)

$18.40M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-59739.42 (Low)

Price

$0.00

Volume

150,019

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

AUSAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Australis Capital

Industry

Pharmaceuticals

CEO

Terry Booth

Headquarters

Las Vegas, NV 89119, US

AUSAF Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

-3%

Net Income Margin

-7%

Return on Equity

0%

Return on Capital

-48%

Return on Assets

-99%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

150.02K

Avg. Volume

3.95K

Financials (TTM)

Gross Profit

$3.97M

Operating Income

$19.38M

EBITDA

$14.13M

Operating Cash Flow

$11.32M

Capital Expenditure

$0.00

Free Cash Flow

$11.32M

Cash & ST Invst.

$581.57K

Total Debt

$2.45M

Australis Capital Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2021YOY CHG

Revenue

$3.10K

+575.8%

Gross Profit

$1.73K

+7200.4%

Gross Margin

55.67%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

18

N/A

Net Income

$31.72K

-101.0%

EBITDA

$6.70M

-317.8%

Quarterly Fundamentals

Name
Q4 2021YOY CHG

Net Cash

$727.69

-82.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$2.45K

-99.8%

Short Term Debt

$0.00

-100.0%

Return on Assets

-98.98%

N/A

Return on Invested Capital

-48.49%

N/A

Free Cash Flow

$5.34K

-228.6%

Operating Cash Flow

$5.37K

-309.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IONKFIonic Brands Corp.
$0.00+0.00%
CBIHCannabis Bioscience International Holdings, Inc.
$0.00+0.00%
LOBEFLobe Sciences Ltd.
$0.10+0.00%
TWSITristar Wellness Solutions Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$10.62-0.05%
NOKNokia
$13.95-0.04%
FFord Motor Company
$13.40-0.07%
POETPoet Technologies
$15.97-0.22%

Questions About AUSAF

What is the current price of Australis Capital?

Australis Capital is trading at N/A per share.

What is the 52-week range for Australis Capital?

Over the past 52 weeks, Australis Capital has traded between N/A and $0.01.

How much debt does Australis Capital have?

Australis Capital total debt is unavailable.

How much cash does Australis Capital have on hand?

Australis Capital reported $582,597.974 in cash and cash equivalents in its most recent financial results.

What is Australis Capital’s dividend yield?

Australis Capital does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.